N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014583 |
| CAS No | NA |
| Mol.F. | C29H37N5O11 |
| Mol.Wt. | 631.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014584 |
| CAS No | NA |
| Mol.F. | C35H37N5O7 |
| Mol.Wt. | 639.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014585 |
| CAS No | NA |
| Mol.F. | C18H26ClN5O6S |
| Mol.Wt. | 475.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014586 |
| CAS No | 959007-11-5 |
| Mol.F. | C14H9ClN2O |
| Mol.Wt. | 256.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014587 |
| CAS No | 41075-14-3 |
| Mol.F. | C14H10Cl2N2O |
| Mol.Wt. | 293.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014588 |
| CAS No | NA |
| Mol.F. | C22H29ClN4O |
| Mol.Wt. | 401.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014589 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014590 |
| CAS No | NA |
| Mol.F. | C14H13N3O |
| Mol.Wt. | 239.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014591 |
| CAS No | 63819-70-5 |
| Mol.F. | C8H18N2O |
| Mol.Wt. | 158.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014592 |
| CAS No | NA |
| Mol.F. | C11H13ClN6O3 |
| Mol.Wt. | 312.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014593 |
| CAS No | NA |
| Mol.F. | C10H13N3O5 |
| Mol.Wt. | 255.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014594 |
| CAS No | NA |
| Mol.F. | C11H8F3N3O |
| Mol.Wt. | 255.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014595 |
| CAS No | NA |
| Mol.F. | C15H16N4O3S |
| Mol.Wt. | 332.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014596 |
| CAS No | NA |
| Mol.F. | C12H8N4O3S |
| Mol.Wt. | 288.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014597 |
| CAS No | NA |
| Mol.F. | C12H9N3O2S |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014598 |
| CAS No | NA |
| Mol.F. | C13H15N3O |
| Mol.Wt. | 229.3 |
| INV STATUS | CUSTOM SYNTHESIS |